08 Sep 2022 Governance

Statement from Leukaemia UK on the death of Her Majesty Queen Elizabeth II

On behalf of the Leukaemia UK team, Chair of Trustees, Chris Corbin OBE, has made the following statement:

“We are extremely saddened to hear the news of the death of Her Majesty Queen Elizabeth II.

Together with the nation and people around the world, we remember a true leader who gave her life to duty. The Queen’s dedication, diligence and integrity were an inspiration to all and we are thankful for an inspiring monarch, who gave her life in service of her country and the Commonwealth.

The Queen’s support for the charity sector has enabled charities in the UK to thrive during her reign and will have a lasting impact for those whom the charities support. 

We share our condolences with the entire Royal Family and especially the Queen’s children and grandchildren. Our thoughts are with them at this very difficult time.” 

Related posts

New campaign launches for the forgotten 500,000 families

17 October 2022

New campaign launches for the forgotten 500,000 families

Patient groups, charities and clinicians unite to raise awareness of half a million vulnerable people, many of whose lives have never returned to normal after the Covid-19 lockdown. A new…

The latest developments and our response

26 January 2026

The latest developments and our response

The government is set to launch the National Cancer Plan for England on 4th February. We are urging policymakers to ensure it delivers meaningful change specifically for people with leukaemia….

Championing groundbreaking therapies and emotional support

25 June 2019

Championing groundbreaking therapies and emotional support

We are proud to be at the forefront of funding innovative research into gene therapy treatments

Widespread coverage of new leukaemia therapy shows promise in first trial patient

12 December 2022

Widespread coverage of new leukaemia therapy shows promise in first trial patient

As you may have seen in the news over the weekend, a clinical trial investigating a new leukaemia treatment has shown promising results. As part of the trial, funded by…